2007 Annual Report
- 2007 Report Home
- Table of Contents for Inventory
- Inventory of Projects (divided by Action Item)
- Executive Summary
- Complete Report (HTML)
- Complete Report (PDF)
Archived Annual Reports
- 2006 Annual Report
- 2005 Annual Report
- 2004 Annual Report
- 2003 Annual Report
- 2002 Annual Report
- 2001 Annual Report
Antimicrobial Resistance Interagency Task Force
2007 Annual Report (Released June 2008)
Table of Contents
Surveillance
- Action Item 1: Identify Organisms and Specific Antimicrobial Drugs for Surveillance
- Action Item 2: With Partners, Design and Implement a National AR Surveillance Plan
- Action Item 3: Develop Standards and Methodologies
- Action Item 4: Address Additional Surveillance Issues Unique to AR
- Action Item 5: Develop and Implement Procedures for Monitoring Antimicrobial Use
- Action Item 6: Identify Methods for Collecting and Disseminating Data on Antimicrobial Use
- Action Item 7: Address Antimicrobial Drug Use as Part of QA in Healthcare Delivery Systems
- Action Item 8: Ensure that Clinical Laboratories Participate in Training and Proficiency Testing
- Action Item 10: Develop Methods to Assess Resistance in Yeasts/Moulds, Parasites and Viruses
- Action Item 15: Provide a Centralized Source of AR Data from Surveillance Systems
- Action Item 16: Provide Data on the Impact of Resistant Organisms and on Prevention & Control
- Action Item 17: Expand Surveillance for Resistance in Sick and Healthy Humans and Animals
- Action Item 18: Evaluate the Usefulness of Monitoring for Infection/Colonization with Resistant Enteric Bacteria
- Action Item 19: Assess Environmental Contamination by Antimicrobial Residues/Resistant Organisms that Enter the Soil or Water
Prevention and Control
- Action Item 21: Identify Factors that Promote/Impede Appropriate Drug Use in Healthcare Settings
- Action Item 22: Develop and Evaluate Appropriate Use Policies in Healthcare Settings
- Action Item 24: Analyze How AR Data Impacts Prescriber Behavior, Health Outcomes and Costs
- Action Item 25: Conduct a Health Education Campaign to Promote Appropriate Antimicrobial Use
- Action Item 26: Implement Educational Interventions to Assist Clinicians in Appropriate Prescribing
- Action Item 27: Integrate Appropriate Use Information into Package Inserts and Promotional Materials
- Action Item 28: Articulate Factors that Support Prescription-Only Dispensing for Systemic Antimicrobials
- Action Item 30: Address Resistant Pathogens with Limited or No Treatment Options
- Action Item 31: Examine the Impact of Federal Reimbursement Policies for Home Treatment, Appropriate Use and Susceptibility Testing
- Action Item 32: Submit Measures for Appropriate Antimicrobial Use to NCQA for Inclusion in HEDIS
- Action Item 33: Evaluate the Potential Impact of Improved Diagnostic Tests
- Action Item 38: Identify Factors that Promote Transmission of Resistant Pathogens in Healthcare/Community
- Action Item 39: Evaluate Infection Control Practices for Healthcare/Community Settings
- Action Item 43: Conduct a Health Campaign to Promote Hand Hygiene and Behaviors that Prevent Transmission
- Action Item 44: Support Infection Control Programs in Healthcare Settings
- Action Item 45: Support Ongoing Public Health Education Campaigns on Food Safety
- Action Item 47: Support Community Programs that Facilitate Vaccinations for Adults and Children
- Action Item 48: Identify Vaccines Useful in Preventing Drug-Resistant Infections
- Action Item 49: Evaluate the Impact of Using Antimicrobials as Growth Promotants in Animals
- Action Item 50: Research Drug Use and the Emergence of Resistant Bacteria in Food Animals
- Action Item 51: Study the Risk of Resistance Related to the Use of Antimicrobials in Plants
- Action Item 52: Develop Rapid Tests for Inspecting Fresh Commodities for Resistant Bacteria
- Action Item 53: Evaluate the Effect of Food Processing/Distribution Methods on AR Emergence and Spread
- Action Item 54: Identify and Evaluate New Food Pasteurization Strategies
- Action Item 55: Assess AR Emergence/Spread due to Environmental Contamination by Antimicrobial Drugs/Resistant Bacteria
- Action Item 57: With Veterinary and Agricultural Communities, Educate Antimicrobial Users About AR Issues
- Action Item 58: Refine/Implement FDA Framework for Approving New Antimicrobials for Use in Food-Animal Production
- Action Item 59: Encourage Involvement of Veterinarians in Decisions on the Use of Systemic Antimicrobials
- Action Item 62: Establish a Mechanism to Obtain Input from External Experts on AR Issues
- Action Item 63: Support Demonstration Projects to Evaluate Strategies to Promote Appropriate Drug Use
- Action Item 64: Use Federal Healthcare Systems as Models for Surveillance/Prevention & Control Activities
- Action Item 65: Identify Strategies to Establish AR Prevention & Control Activities as Part of Quality Monitoring Programs
Research
- Action Item 67: Support Research, Including High Risk/Payoff Research in Nontraditional Fields
- Action Item 68: Conduct a Government-Wide Assessment of the Scope and Composition of AR Research
- Action Item 69: Ensure that the Requisite Expertise Is Applied to the Review Process for Funding Quality AR Research
- Action Item 70: Provide Tools to Identify Targets for the Development of Diagnostics, Therapeutics and Interventions
- Action Item 71: Encourage AR Data Sharing Between Industry and the Research Community
- Action Item 72: Offer Training/Research Opportunities to Bring New Researchers into the Field
- Action Item 73: Organize Conferences that Address Research Issues Relating to AR
- Action Item 74: Explore the Need for Studies on Therapeutic Agents for Treating Resistant Pathogens
- Action Item 75: Conduct Clinical Studies on AR Issues Unlikely to Be Studied in the Private Sector
- Action Item 76: Develop, Test and Evaluate New Diagnostics for Human/Veterinary Use
- Action Item 77: Encourage Basic/Clinical Research on the Development and Appropriate Use of Vaccines
- Action Item 78: Encourage Basic/Clinical Research on Approaches to Preventing or Treating Infections
Product Development
- Action Item 80: Identify Ways to Promote Development of AR Products for Which Market Incentives Are Inadequate
- Action Item 82: Continue to Streamline the Regulatory Process to Bring AR Products to Market
Content Source: National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID)
Page last modified: September 23, 2008
Page last modified: September 23, 2008